Telogen Effluvium: diffuse hair loss explained
Telogen effluvium is classified as a non-scarring (non-cicatricial) alopecia within dermatology. Unlike scarring forms of hair loss, the follicular structure remains preserved, making recovery biologically possible once normal hair cycle regulation resumes.
Telogen effluvium is a common form of diffuse, non-scarring hair loss characterized by a temporary disruption of the normal hair growth cycle.
It occurs when a higher number of hair follicles shift prematurely from the growth phase (anagen) into the resting phase (telogen), resulting in increased shedding weeks to months later.
Various internal and external triggers may contribute to this cycle shift, including physiological stress, illness, hormonal fluctuations, or significant life events.
For a structured overview comparing alopecia androgenetica, alopecia areata, and scarring conditions, see our full guide to types of hair loss and medical classification.
What is telogen effluvium?
Telogen effluvium is a non-scarring (non-cicatricial) form of diffuse hair loss in which a higher-than-normal number of hair follicles prematurely shift into the resting (telogen) phase of the hair growth cycle.
Unlike scarring alopecias such as frontotemporal fibrosing alopecia, the hair follicle structure remains intact. This means that regrowth is biologically possible once the underlying trigger resolves.
Within dermatology, telogen effluvium is classified as a reactive hair shedding disorder, most commonly triggered by systemic or physiological stress, illness, hormonal changes, surgery, or significant emotional strain. It reflects a temporary disturbance of the hair growth cycle rather than intrinsic follicle miniaturisation.
Under normal conditions, only a small percentage of hair follicles are in the telogen phase at any given time. In telogen effluvium, this balance is temporarily disrupted, leading to increased shedding across the entire scalp rather than in specific regions.
Importantly, telogen effluvium affects both men and women and is one of the most common non-hereditary causes of noticeable hair shedding. It represents a cycle shift, not permanent follicle damage.
Unlike alopecia androgenetica, telogen effluvium does not follow a progressive pattern of follicular miniaturisation and typically presents as diffuse shedding across the whole scalp.
How much hair shedding is normal per day?
Understanding how much hair shedding is considered normal helps distinguish temporary diffuse shedding from progressive hair thinning.
Under normal conditions, it is typical to shed 50–100 hairs per day. Because individual hairs cycle independently, this daily shedding often goes unnoticed.
In telogen effluvium, a larger proportion of hair follicles enter the resting (telogen) phase simultaneously. As a result, daily shedding may increase significantly, sometimes exceeding 150–300 hairs per day.
Common observations include:
- Noticeable hair accumulation during washing
- Increased shedding while brushing
- Hair appearing on clothing or pillows
- Diffuse thinning rather than clearly defined bald areas
Increased shedding alone does not automatically indicate permanent hair loss. The distribution pattern, timing, and associated triggers determine the underlying mechanism.
In telogen effluvium, the defining feature is the combination of diffuse distribution and delayed timing, not progressive follicular damage.
What telogen effluvium IS – and IS NOT
Telogen effluvium is frequently misunderstood. Clarifying what it represents, and what it does not, helps prevent confusion with other forms of hair loss.
Telogen effluvium is:
- A biologically driven disruption of the hair growth cycle
- Characterised by diffuse, widespread shedding
- Usually triggered by a temporary internal stressor
- Typically reversible over time
Telogen effluvium is NOT:
- A hereditary form of hair loss
- Pattern-based thinning at the temples, crown, or part line
- Caused by shampoo use or routine hair care practices
- A condition involving permanent follicle destruction
This distinction is essential. Telogen effluvium is often confused with hereditary pattern hair loss, despite having a very different cause, distribution, and expected course.
Diffuse or sudden hair shedding can have multiple underlying causes, and different forms of hair loss may overlap, particularly in early stages. Understanding the pattern and timing of hair changes is therefore critical before drawing conclusions.
Not sure if this applies to you?
The TRIX Hair Check guides you through a short, structured assessment based on hair pattern, timing and personal factors to help clarify which type of hair loss is most likely.
If shedding began 6–12 weeks after a trigger and affects the entire scalp, telogen effluvium is often the most likely explanation.
Recovery is gradual and follows hair-cycle regulation over months. During this phase, structured support is often most relevant when used consistently.
How telogen effluvium is identified in practice
Telogen effluvium is not diagnosed based on a single symptom. In clinical practice, assessment focuses on distribution pattern, timing of onset, progression over time, and recent triggering events. This structured approach helps distinguish telogen effluvium from alopecia androgenetica and other causes of diffuse hair loss.
This structured approach helps distinguish telogen effluvium from chronic or pattern-based forms of hair loss and reduces the risk of misclassification.
In clinical evaluation, the absence of follicular miniaturisation and scarring helps differentiate telogen effluvium from alopecia androgenetica and scarring alopecias.
No single sign is decisive
Hair shedding can occur for many reasons, and similar symptoms may reflect different underlying mechanisms. For this reason, clinicians do not rely on shedding alone, visible thinning alone, or a single triggering event to identify telogen effluvium.
Instead, diagnosis emerges from the overall clinical picture and its evolution over time.
Key elements clinicians consider
When assessing telogen effluvium, clinicians do not rely on a single symptom or observation. Instead, evaluation is based on a combination of clinical features considered together. No single element is decisive on its own; assessment is cumulative and focuses on patterns, timing, and contextual factors rather than isolated signs.
Clinicians evaluate telogen effluvium using a pattern-based framework rather than isolated symptoms.
-
Timing and onset
Whether hair shedding began weeks to months after a potential trigger, rather than developing gradually over years. A delayed onset following stress, illness, or hormonal change is characteristic.
-
Pattern of hair loss
Whether shedding is diffuse and evenly distributed across the scalp, without preferential involvement of the temples, crown, or frontal hairline.
-
Course over time
Whether shedding appears sudden or subacute and whether it stabilises or improves over time, rather than progressing steadily.
-
Hair follicle integrity
The absence of signs suggesting follicular damage, scarring, or progressive miniaturisation. In telogen effluvium, follicles remain structurally intact.
-
Contextual factors
Recent physical, hormonal, emotional, nutritional, or systemic changes that could plausibly disrupt the hair growth cycle.
Why differentiation can be challenging
Because telogen effluvium often presents as sudden and noticeable shedding, it is frequently misunderstood.
Common assumptions include:
- “I am going bald permanently.”
- “The shedding means my hair follicles are dying.”
- “Stress caused permanent damage.”
- “All hair loss must be hereditary.”
In telogen effluvium, the hair follicles remain biologically intact. The shedding reflects a temporary shift in the hair growth cycle rather than structural follicle loss.
Understanding this distinction is essential to avoid unnecessary anxiety and inappropriate treatment decisions. Telogen effluvium may coexist with other forms of hair loss, most commonly alopecia androgenetica (pattern hair loss). In such cases, increased shedding can make underlying pattern-based thinning more noticeable.
This overlap is particularly relevant when telogen effluvium occurs in individuals with early androgen-sensitive thinning and it can blur the clinical picture, especially in early stages, which is why assessment focuses on patterns and timing rather than assumptions.
Because telogen effluvium can overlap with pattern hair loss, differentiation may require comparison with Alopecia Androgenetica vs Telogen Effluvium.
For a broader medical overview of hair loss types and how they differ, see our complete classification of hair loss conditions.
If shedding continues beyond expected timelines or is accompanied by progressive pattern-based thinning, evaluation for coexisting conditions such as alopecia androgenetica may be appropriate.
The normal hair growth cycle
Hair growth follows a repeating biological cycle that occurs independently within each follicle. This asynchronous rhythm allows the scalp to maintain visible density, even though individual hairs are constantly cycling between growth, transition, and rest phases.
The cycle consists of three main phases:
-
Anagen (growth phase)
The hair grows actively. In healthy hair follicles, this phase can last several years. In healthy scalp conditions, 80–90% of follicles are in anagen at any given time.
-
Catagen (transition phase)
Hair growth slows as the follicle prepares to enter a resting period. This short transitional phase lasts approximately 2–3 weeks.
-
Telogen (resting and shedding phase)
The hair is eventually shed and replaced by a new growing hair. Normally, only 10–15% of follicles are in telogen at one time.
At any given time, most hair follicles are in the growth phase, while a smaller proportion are in the resting phase. Because follicles cycle independently, daily hair shedding is a normal and healthy process that usually goes unnoticed.
✓ In telogen effluvium, this balance shifts abnormally, with a significantly higher percentage of follicles entering telogen simultaneously, resulting in increased diffuse shedding.
Understanding the normal hair growth cycle helps explain why telogen effluvium causes increased shedding without damaging the hair follicles.
For individuals experiencing temporary telogen effluvium, recovery-focused support may be helpful during the regrowth phase. Learn more about TRIX Basic Beta.
How telogen effluvium differs from follicular miniaturisation
Unlike alopecia androgenetica, telogen effluvium does not involve progressive follicular miniaturisation. The follicle structure remains intact, and the disturbance affects timing of the cycle rather than follicle size.
What happens with telogen effluvium?
Telogen effluvium develops when a temporary internal trigger disrupts the normal distribution of hair follicles within the growth cycle. The disturbance affects timing rather than structure, the follicles remain intact, but a larger-than-normal proportion prematurely shift into the resting (telogen) phase.
As a result, increased hair shedding typically becomes noticeable weeks to months after the triggering event, when the resting hairs are released from the scalp.
What happens at the level of the hair follicle?
Under normal conditions, individual hair follicles cycle independently through three biological phases: growth (anagen), transition (catagen), and rest (telogen). This staggered rhythm maintains stable overall hair density, even though individual hairs are continuously shed and replaced.
In telogen effluvium, the structure of the follicle remains intact. What changes is the distribution of follicles within the hair cycle.
Specifically:
- The duration of the anagen (growth) phase shortens
- A higher proportion of follicles enter telogen simultaneously
- Shedding occurs once the telogen phase completes
- Follicle size remains unchanged (no miniaturisation)
Because the follicle itself is not damaged, it retains the ability to re-enter the growth phase and produce new hair once normal cycling resumes.
This distinguishes telogen effluvium from alopecia androgenetica, where progressive follicular miniaturisation gradually reduces follicle size and long-term growth capacity.
Why shedding appears diffuse
Unlike androgen-sensitive pattern hair loss (alopecia androgenetica), telogen effluvium does not selectively affect specific regions such as the temples or crown.
Instead, follicles across the entire scalp are involved.
Because a larger proportion of follicles shift phases at roughly the same time, this results in:
- Widespread, even shedding
- No clearly defined bald patches
- A general reduction in perceived density
Hair thinning is therefore perceived evenly rather than in a recognisable pattern.
In most cases, the hairline and scalp distribution remain unchanged.
Why the onset often feels sudden
Although telogen effluvium is triggered by a specific internal event, visible shedding is delayed.
In most cases, shedding begins 6–12 weeks after the triggering factor. This delay occurs because hair follicles must first transition into the resting (telogen) phase before shedding becomes visible.
By the time hair loss is noticed, the original trigger may already have resolved. This biological delay often makes the onset feel sudden and unexpected.
The 6–12 week interval between trigger and shedding is considered a key diagnostic feature of telogen effluvium.
Why telogen effluvium is usually temporary
Telogen effluvium reflects a reversible shift in hair cycle timing rather than permanent follicle damage.
Once the underlying trigger resolves or stabilises, the hair growth cycle gradually normalises.
Over time:
- Excessive shedding decreases
- Follicles return to independent cycling
- New growth becomes visible
In uncomplicated cases, full density often gradually returns once cycling stabilises.
However, persistent shedding beyond 6–9 months warrants evaluation for chronic telogen effluvium or overlapping conditions.
Recovery speed varies depending on trigger severity, duration, and overall scalp health.
What happens during recovery?
Recovery from telogen effluvium follows a biological sequence. Improvement typically occurs in shedding before visible density returns.
Recovery is not an immediate cosmetic change, but a gradual restoration of hair cycle balance.
Shedding gradually decreases
The first sign of recovery is usually a reduction in daily shedding.
This may take time, because hairs that have already entered telogen still need to complete their cycle and be released.
Continued shedding for several weeks after the trigger resolves does not necessarily indicate ongoing damage.
Follicles resume normal cycling
Over time, follicles re-enter the growth (anagen) phase and resume their independent rhythm.
Shedding stabilises before visible thickening occurs.
This stage reflects biological recovery at the follicle level.
New hair growth becomes visible
Regrowth hairs are initially fine and short.
They may be noticeable along the hairline or parting.
Because scalp hair grows approximately 1 cm per month, visible density improvement lags behind biological recovery.
In telogen effluvium, improvement in shedding typically precedes visible regrowth.
How long does telogen effluvium last?
Telogen effluvium typically involves 3–6 months of active shedding once hair loss becomes noticeable.
Because shedding begins several weeks after the triggering event, the total timeline from trigger to visible recovery often spans 6–9 months.
In most cases:
- Shedding begins 6–12 weeks after the trigger
- Active shedding lasts several months
- Regrowth begins once follicles re-enter anagen
- Visible density improvement lags behind shedding reduction
Recovery unfolds over months rather than weeks.
Short-term fluctuations in shedding are common and do not necessarily indicate worsening or relapse.
For a detailed breakdown of timelines, phases, and regrowth expectations, see our article: How long does telogen effluvium last?
When recovery may take longer
Shedding that persists beyond 6 months is classified as chronic telogen effluvium and warrants clinical assessment.
If progressive pattern-based thinning develops, an overlapping androgenetic component may be present.
Individual timelines vary depending on:
- Trigger severity
- Baseline hair density
- Duration of physiological stress
- Coexisting hair conditions
✓ In telogen effluvium, improvement in shedding usually occurs before visible regrowth.
Signs telogen effluvium is improving
Early signs of recovery include:
- Gradual reduction in daily shedding
- No expansion of thinning areas
- Fine regrowth hairs along the hairline or parting
- Stabilisation of perceived density
Because hair grows slowly, cosmetic improvement follows biological recovery.
Lack of immediate thickening does not mean recovery is not occurring.
✓ Telogen effluvium recovery is gradual. Improvement in shedding typically precedes visible regrowth, and cosmetic density changes follow biological recovery.
Telogen effluvium in men and women
Telogen effluvium affects both men and women and reflects the same biological mechanism in all individuals: a temporary disruption of the hair growth cycle resulting in diffuse shedding.
While the underlying process is identical, presentation and context may differ due to hormonal background, life stage, and baseline hair patterns.
Telogen effluvium in women
In women, telogen effluvium is particularly common and frequently associated with hormonal or physiological transitions.
Common contexts include:
- Pregnancy and the postpartum period
- Starting or stopping hormonal contraception
- Menopause
- Significant emotional or physical stress
These factors do not directly damage hair follicles but may temporarily disrupt hair cycle regulation.
Shedding in women typically presents as:
- Even thinning across the scalp
- Increased hair loss during washing or brushing
- A visibly thinner parting or ponytail
- Preserved frontal hairline
Because overall density decreases evenly, telogen effluvium in women is sometimes misinterpreted as early alopecia androgenetica. Careful evaluation of timing and pattern helps differentiate the two.
-
Diffuse thinning across the scalp
-
Increased hair loss during washing or brushing
-
A noticeably thinner ponytail or parting
Telogen effluvium in men
In men, telogen effluvium is less frequently discussed than hereditary hair loss but can still be a significant cause of sudden shedding.
Common triggers include:
- Acute or chronic psychological stress
- Illness, infection, or surgery
- Rapid weight loss
- Nutritional imbalance
When it occurs, telogen effluvium in men typically presents as:
- Diffuse shedding rather than pattern-based thinning
- Even reduction in density across the scalp
- Noticeable increase in daily hair fall
Because many men already have awareness of alopecia androgenetica, telogen effluvium may be confused with progression of pattern hair loss, particularly when both conditions coexist.
Why gender-specific context matters
Although the biological mechanism of telogen effluvium is the same in men and women, contextual factors influence how it is recognised.
Differences in:
- Hormonal fluctuations
- Life-stage transitions
- Baseline hair density
- Pre-existing pattern thinning
can affect how shedding is perceived.
Understanding these contextual variables helps:
- Reduce misinterpretation
- Set realistic recovery expectations
- Distinguish telogen effluvium from other forms of hair loss
In some individuals, telogen effluvium may coexist with androgen-sensitive thinning, further reinforcing the importance of structured pattern-based assessment.
Triggers and risk factors in telogen effluvium
Telogen effluvium is a non-scarring (non-cicatricial) form of hair loss in which the hair follicles remain structurally intact. Unlike scarring alopecias such as frontotemporal fibrosing alopecia (FFA), the follicular unit is not permanently damaged.
Instead of destroying hair follicles, telogen effluvium reflects a temporary shift in the hair growth cycle. A systemic physiological or psychological stressor causes an increased proportion of follicles to prematurely enter the resting (telogen) phase.
Because this shift affects timing rather than follicle integrity, recovery is biologically possible once the underlying trigger stabilizes.
-
Physical stressors
Physical stress placed on the body is one of the most common triggers of telogen effluvium.
During periods of acute physiological strain, the body temporarily redirects energy toward essential survival functions. Hair growth, being non-essential, may be downregulated.
Common physical triggers include:
- Acute illness or infection
- High fever
- Surgery or medical procedures
- Significant injury or trauma
Hair shedding typically becomes noticeable 6–12 weeks after the event, not immediately, due to the biological delay of the hair cycle.
-
Hormonal changes
Hormonal fluctuations can strongly influence hair cycle timing, even when hormone levels remain within physiological ranges.
Common hormonal contexts associated with telogen effluvium include:
- Pregnancy and the postpartum period
- Starting or stopping hormonal contraception
- Menopause or perimenopause
- Thyroid-related hormonal shifts
In these situations, follicles may synchronously enter the telogen phase, resulting in diffuse shedding.
Importantly, this differs from alopecia androgenetica, where hormone sensitivity leads to progressive miniaturisation rather than temporary cycle disruption.
-
Emotional and psychological stress
Emotional and psychological stress is one of the most common triggers. For a detailed explanation of how stress influences the hair growth cycle and why shedding often appears delayed, see: Stress hair loss: causes, timeline and recoveryEmotional stress can act as a biological trigger when prolonged or severe.
Although stress alone does not cause hereditary hair loss, sustained psychological strain can disrupt hair cycle regulation and precipitate telogen effluvium.
Examples include:
- Prolonged emotional strain
- Major life events
- Chronic anxiety
- Burnout
Because shedding is delayed, the link between stress and hair loss is not always immediately recognised.
Cumulative stress exposure may be sufficient, a single dramatic event is not always required.
-
Nutritional and metabolic factors
Adequate nutrition is essential for normal hair cycling.
Sudden dietary changes or metabolic disturbances may influence follicle behavior and contribute to telogen effluvium.
Potential contributing factors include:
- Rapid weight loss
- Restrictive dieting
- Nutritional deficiencies
- Prolonged caloric restriction
- Metabolic stress
In these contexts, telogen effluvium reflects a temporary adaptive response rather than permanent follicular damage.
-
Medications and systemic changes
Certain medications and systemic physiological changes can alter hair cycle dynamics.
Examples include:
- Initiation or discontinuation of long-term medication
- Hormonal treatments
- Major systemic adjustments
Not all individuals experience shedding under the same circumstances, highlighting the role of individual susceptibility.
Why triggers affect individuals differently
Exposure to a trigger does not guarantee telogen effluvium.
Severity and likelihood depend on:
- Baseline hair density and follicular reserve
- Duration and intensity of the trigger
- Individual biological sensitivity
- Overall health and recovery capacity
In some individuals, multiple triggers overlap, increasing the likelihood of noticeable shedding.
When telogen effluvium may coexist with other hair loss types
Telogen effluvium can occur alongside other forms of hair loss, including alopecia androgenetica.
In such cases, diffuse shedding may unmask underlying pattern-based thinning, making hair loss appear sudden or more severe.
Because overlapping mechanisms can blur the clinical picture, structured assessment is often required to clarify the dominant process.
Persistent shedding combined with progressive pattern thinning suggests an androgen-sensitive component rather than isolated telogen effluvium.
Not all triggers are obvious or act in isolation. Learn how multiple triggers can overlap, recur, or remain unclear in practice.
Can telogen effluvium cause permanent hair loss?
Telogen effluvium itself does not permanently damage hair follicles.
It is classified as a non-scarring (non-cicatricial) alopecia, meaning the follicular units remain structurally intact and capable of regrowth.
In typical cases, increased shedding reflects a temporary disruption of the hair growth cycle rather than follicle destruction.
However, further evaluation is appropriate if:
- Shedding persists beyond expected recovery timelines (6–9 months)
- There is evidence of progressive pattern-based thinning
- Patchy hair loss develops
- Signs of inflammatory or scarring alopecia are present
When permanent thinning occurs, it is usually due to an underlying or coexisting condition rather than telogen effluvium itself.
Can telogen effluvium coexist with other hair loss types?
Yes.
Telogen effluvium can occur alongside other forms of hair loss, most commonly alopecia androgenetica.
In these situations, diffuse shedding may:
- Make pre-existing thinning more noticeable
- Accelerate visible density reduction
- Unmask an underlying pattern-based hair loss
This does not mean telogen effluvium causes other types of alopecia. Rather, it reflects the fact that multiple hair loss mechanisms can operate simultaneously.
Overlap is particularly common in individuals with genetic sensitivity to androgens.
See the full overview of hair loss conditions for a medical classification framework.
Telogen effluvium and alopecia androgenetica
Alopecia androgenetica is a progressive, pattern-based condition driven by genetic and hormonal sensitivity.
Telogen effluvium, by contrast, is a reactive and typically reversible shift in hair cycle timing.
When both are present, you may observe:
- Diffuse shedding superimposed on patterned thinning
- Reduced density in areas already genetically predisposed
- More rapid visible change than expected
As telogen effluvium resolves, shedding decreases, but underlying pattern thinning may persist.
→ Learn more about alopecia androgenetica and how it differs from telogen effluvium.
Why overlap can be confusing
Early stages can make it difficult to distinguish between:
- Acute telogen effluvium
- Early alopecia androgenetica
- A combination of both
Because telogen effluvium has a delayed onset, the original trigger may no longer be obvious, further complicating interpretation.
Self-assessment based solely on visible thinning is often misleading.
How coexistence is assessed in practice
Clinical evaluation focuses on:
- Distribution pattern of thinning
- Timing of onset relative to triggers
- Progression over time
- Presence or absence of follicular miniaturisation
This structured assessment clarifies whether:
- Telogen effluvium is the primary driver
- Pattern-based thinning is dominant
- Both processes are contributing
Stress-related shedding may occur alongside alopecia androgenetica.
Why clarification matters
Distinguishing between mechanisms is essential because:
- Recovery expectations differ
- Management strategies differ
- Long-term prognosis differs
Without differentiation, individuals may either overestimate the severity of temporary shedding or underestimate progressive pattern thinning.
Other common hair loss patterns
Hair loss does not always follow a single mechanism.
If your symptoms do not fully align with telogen effluvium, consider other clinically recognised conditions.
Alopecia androgenetica
A progressive, androgen-sensitive hair loss pattern affecting specific regions such as the temples, crown, or central part line.
→ Learn more about alopecia androgenetica.
Alopecia areata
An autoimmune condition characterised by sharply defined patchy hair loss. Unlike telogen effluvium, shedding is typically localised rather than diffuse.
Not sure which type applies to you?
Hair loss patterns can overlap. A structured assessment such as the TRIX Hair Check helps clarify the most likely cause based on timing, distribution, and personal factors.
Telogen effluvium vs alopecia androgenetica
This comparison clarifies the difference between diffuse, often temporary shedding (telogen effluvium) and pattern-based, progressive hereditary thinning (alopecia androgenetica).
| Feature | Telogen effluvium | Alopecia androgenetica |
|---|---|---|
| Onset | Often sudden (typically noticeable 6–12 weeks after a trigger) | Gradual, over months to years |
| Pattern | Diffuse across the scalp | Pattern-based (e.g., temples/crown or central parting) |
| Miniaturisation | No (follicles typically remain structurally intact) | Yes (progressive miniaturisation of sensitive follicles) |
| Course over time | Usually temporary; stabilises once the trigger resolves | Typically progressive without targeted long-term support |
| Trigger | Often identifiable stressor (illness, surgery, hormonal shift, stress, diet) | Genetic sensitivity to hormonal signals (incl. DHT) |
If you notice both diffuse shedding and progressive pattern thinning, overlap is possible and further evaluation is often appropriate.
Targeted support in telogen effluvium
Telogen effluvium is primarily a disorder of hair cycle timing.
Because the follicle structure remains intact, recovery depends on allowing the hair growth cycle to rebalance.
There is no instant solution that reverses shedding overnight. Management focuses on:
- identifying and addressing the underlying trigger
- supporting normal hair cycle regulation
- maintaining adequate nutritional and physiological balance during recovery
In some cases, structured nutritional support may be considered as part of a broader, recovery-oriented approach. This does not replace time-dependent biological recovery, but may help support follicular function during periods of increased shedding.
TRIX Basic Beta is formulated for individuals experiencing stress- or hormone-related diffuse hair shedding consistent with telogen effluvium.
It is designed to:
- support normal hair cycle balance
- contribute to healthy hair growth during recovery
- provide nutritional support during periods of physiological or emotional stress
Because telogen effluvium follows a delayed and gradual recovery pattern, any supportive approach requires consistent use over several months. Supplements should be viewed as adjunctive support, not as standalone treatment.
Clinical summary: telogen effluvium at a glance
Telogen effluvium is a temporary, non-scarring form of diffuse hair shedding caused by a disruption in normal hair cycle regulation.
Key characteristics
- Sudden or increased shedding across the entire scalp
- Often triggered by stress, illness, hormonal change, or metabolic imbalance
- Delayed onset (typically 6–12 weeks after trigger). This delayed timing is characteristic of stress-related diffuse shedding. Learn more about why hair falls out weeks after stress →
- Hair follicles remain structurally intact
- Regrowth is biologically possible once the trigger resolves
In most cases, improvement in shedding occurs before visible density recovery.
Telogen effluvium reflects a functional shift in hair cycling, not permanent follicular damage.
When to seek medical evaluation
Telogen effluvium is often self-limiting. However, further evaluation is recommended when:
- shedding persists beyond 6 months
- hair density continues to decline progressively
- thinning becomes pattern-based rather than diffuse
- patchy hair loss develops
- shedding is accompanied by scalp redness, scaling, or discomfort
- there is uncertainty about the underlying mechanism
Persistent or worsening hair loss may indicate:
- chronic telogen effluvium
- overlapping alopecia androgenetica
- nutritional or metabolic imbalance
- another underlying hair loss condition
A structured dermatological assessment helps distinguish temporary diffuse shedding from progressive pattern hair loss and guides appropriate next steps.
Gaining clarity about your situation
Hair loss can feel uncertain, especially when shedding patterns change or follow a stressful period. Determining whether hair loss is cycle-related, pattern-based, or influenced by overlapping factors is essential for setting realistic expectations and choosing appropriate next steps.
Because telogen effluvium often overlaps with other forms of hair loss, relying on a single sign, such as increased shedding, can be misleading. A structured evaluation that considers timing, distribution, progression, and individual context provides a clearer and more clinically meaningful perspective.
The role of structured assessment
In clinical practice, hair loss is never assessed based on one symptom alone. Instead, evaluation integrates:
- pattern of thinning
- onset and timeline
- progression over time
- contextual triggers
- baseline hair characteristics
The TRIX Hair Check brings these elements together in a short, structured assessment. Rather than focusing on isolated symptoms, it helps clarify whether telogen effluvium, androgen-sensitive thinning, or overlapping mechanisms are most likely involved.
Supporting informed next steps
Understanding the underlying mechanism allows for:
- realistic expectations about recovery
- appropriate timing of reassessment
- targeted long-term support when needed
If you are unsure how the information on this page applies to your situation, a structured assessment provides a clearer starting point.
Based on 20+ years of dermatological expertise
Telogen effluvium in clinical perspective
Telogen effluvium is a reactive, non-scarring form of diffuse hair shedding that follows a systemic or physiological trigger. Unlike pattern-based hair loss, the follicular structure remains intact, which means recovery is biologically possible once normal hair cycle regulation resumes.
In clinical practice, diagnosis is not based on shedding alone. Assessment focuses on:
- timing of onset
- distribution of thinning
- progression over time
- recovery behaviour
Distinguishing temporary cycle disruption from pattern-based miniaturisation or overlapping conditions is essential for accurate interpretation and appropriate next steps.
Understanding this distinction reduces unnecessary concern and supports realistic expectations about recovery.
Frequently asked questions about telogen effluvium
Collapsible content
What is telogen effluvium?
Telogen effluvium is a form of diffuse hair shedding in which a larger-than-normal number of follicles temporarily shift into the telogen (resting) phase. This leads to noticeable increased daily shedding across the scalp.
Is telogen effluvium permanent?
Usually not. Telogen effluvium is non-scarring, meaning follicular structure remains intact. Recovery is often possible once the trigger stabilises or resolves, although it typically takes months.
How soon after a trigger does telogen effluvium start?
Shedding is often noticed 6–12 weeks after a trigger (such as illness, surgery, hormonal change, or severe stress). The delay reflects the timing of the hair cycle shift.
How long does telogen effluvium usually last?
Active shedding often lasts around 3–6 months. The overall timeline from trigger to visible improvement may be 6–9 months or longer, because recovery and regrowth follow hair-cycle biology.
How many hairs per day is normal to shed?
Shedding around 50–100 hairs per day is often normal. In telogen effluvium, the number can be noticeably higher because more follicles are in telogen at the same time. Timing, pattern, and duration matter more than the count alone.
What commonly triggers telogen effluvium?
Telogen effluvium may follow physical or emotional stress, illness/fever, surgery, childbirth, rapid weight change, nutritional or iron deficiency, medication changes, and hormonal shifts.
Can stress cause telogen effluvium?
Yes. Severe or prolonged stress can disrupt hair-cycle regulation and trigger telogen effluvium. In practice, multiple factors may overlap.
How can I recognise telogen effluvium?
It typically presents as diffuse shedding across the scalp, often noticeable during washing or brushing, without sharply defined bald patches. Onset is often relatively sudden and fits a trigger weeks to months earlier.
Is telogen effluvium the same as alopecia androgenetica?
No. Alopecia androgenetica usually causes gradual, pattern-based thinning due to follicular miniaturisation. Telogen effluvium causes diffuse shedding due to a temporary shift in the hair cycle.
Can telogen effluvium coexist with alopecia androgenetica?
Yes. Telogen effluvium can make pre-existing pattern thinning more noticeable. Timing and pattern together help determine which component is dominant.
Does telogen effluvium cause bald patches?
Usually not. Telogen effluvium is typically diffuse. Well-defined round or oval bald patches are more characteristic of alopecia areata.
What are signs telogen effluvium is improving?
Shedding often decreases before visible density improves. Fine regrowth hairs may appear along the hairline or parting, while cosmetic thickening usually lags by months.
When is telogen effluvium considered chronic?
If diffuse shedding persists beyond roughly 6 months or repeatedly recurs. In that situation, assessment for ongoing triggers, overlap with other hair loss types, or underlying deficiencies is often appropriate.
Can telogen effluvium cause permanent follicle damage?
Telogen effluvium itself is non-scarring and usually does not permanently damage follicles. If shedding is persistent, progressive, or associated with scalp inflammation, other causes should be considered.
When should I seek medical evaluation for telogen effluvium?
Consider evaluation if shedding lasts longer than 6 months, progresses rapidly, becomes pattern-based, includes bald patches, is accompanied by scalp pain/redness/scaling, or follows significant illness or medication change.
What assessments can help evaluate diffuse shedding?
Clinicians evaluate pattern and timing and may use dermoscopy. Depending on context, targeted blood tests can be useful, for example when deficiency or hormonal imbalance is suspected.
This page provides general educational information and does not replace medical diagnosis or treatment. For personalized medical advice, consult a qualified healthcare professional.
View the full overview of types of hair loss and medical classification →
